Walgreens, Rite Aid To Cut $2B Off Deal Value In Effort To Win Regulatory Approval

Walgreens

After struggling to gain regulatory approval for their proposed merger, Walgreens Boots Alliance and Rite Aid just agreed to reduce the merger price by at least $2B.

On Monday the two firms agreed to sell off 200 more stores, lowering Rite Aid’s value to between $6.8B and $7.4B, the Wall Street Journal reports. When Walgreens agreed to buy its rival in October 2015 the sales price of $9 a share valued Rite Aid at $9.4B.

Executives at both firms hope selling off more stores will make the deal less troublesome to the Federal Trade Commission, which took issue with the merger since it would create a drugstore chain totaling over 10,000 U.S. stores. Earlier this month Walgreens indicated it has no backup plan should the merger fail. [WSJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's National Newsletters
Related Stories

Democrats Win Congress As America's Data Center Backlash Hits The Ballot Box

U.S. Hotel RevPAR Surges 7% In Q3, But Expect Easing From Here

Stock Sell-Off, Bond Market Jitters Signal Financing Trouble For AI Data Centers

Wereldhave Sells €63M Shopping Center To French Investor

Starwood Launches Residential Land JV Targeting $1B In Annual Originations

RealPage Antitrust Case Ends With Nearly $360M In Settlements For Renters

ZOM Living Entity Files For Bankruptcy To Fund Fight To Overturn $323M Judgment

How Colliers Engineering Helped A Struggling Dam Move To The Head Of The Class

Real Estate's Bottom Rung Is Getting Harder To Reach — And Now It Wants AI Skills

Banks Are Manhattan's Latest Hot Retail Tenant

OpenAI Plans Data Center Rebrand To Make Projects Palatable To Voters

The Geo Group To Reopen 2,329-Bed Immigration Facility In Texas